Dinitrochlorobenzene immunotherapy of human warts.
A joint clinical study was conducted to test the effectiveness of topical dinitrochlorobenzene ointment in the treatment of warts. The feasibility of this therapeutic modality was demonstrated by the fact that warts completely cleared in more than 80 percent of the eighty-four patients enrolled in the study. Healing time average from three to six weeks. Complications incurred are presented and ways to minimize them are reviewed.
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D002648:Child; D004137:Dinitrochlorobenzene / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007111:Immunity, Cellular; D007167:Immunotherapy; D008297:Male; D009578:Nitrobenzenes / Q000627:therapeutic use*; D014860:Warts / Q000276:immunology / Q000628:therapy*
D004137:Dinitrochlorobenzene; D009578:Nitrobenzenes